BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11341378)

  • 1. Authors do not believe article provides evidence of vaccine efficacy.
    Morley PS; Townsend HG; Haines DM
    Am J Vet Res; 2001 May; 62(5):648. PubMed ID: 11341378
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions validity of equine vaccine field studies.
    Piontkowski MD
    J Am Vet Med Assoc; 1999 Sep; 215(5):620-1. PubMed ID: 10476701
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new product in the vaccination gap: the vector vaccine. Merial introduced an innovative influenza-tetanus vaccine for horses].
    Hulsen J
    Tijdschr Diergeneeskd; 2003 May; 128(9):295-6. PubMed ID: 12769041
    [No Abstract]   [Full Text] [Related]  

  • 4. Efforts to pre-empt an equine influenza epidemic.
    Mumford J; Cardwell J; Daly J; Newton R
    Vet Rec; 2003 Mar; 152(13):405-6. PubMed ID: 12696710
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the effectiveness of the response to equine influenza in the Australian outbreak and the potential role of early vaccination.
    Garner MG; Cowled B; East IJ; Moloney BJ; Kung N
    Aust Vet J; 2011 Jul; 89 Suppl 1():143-5. PubMed ID: 21711314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
    Minke JM; Toulemonde CE; Dinic S; Cozette V; Cullinane A; Audonnet JC
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S76-80. PubMed ID: 17559865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on a test vaccine for equine influenza virus. II. Field trials.
    Nagamine T; Asahara T; Ide S; Yoshimura M; Igarashi Y
    Kitasato Arch Exp Med; 1975 Sep; 48(2-3):69-82. PubMed ID: 183037
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination of horses against equine influenza using a polyvalent inactivated vaccine].
    Cottereau P; Petermann HG; Fayet MT; Papageorgiou C; Valette L; Vicaria JM
    Bull Acad Vet Fr; 1969 Apr; 42(4):141-6. PubMed ID: 5408039
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic requirements and control for equine influenza vaccines.
    Goff MT
    J Am Vet Med Assoc; 1969 Jul; 155(2):284-6. PubMed ID: 5816112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.